1440796-75-7

1440796-75-7 structure

Name: Opiranserin hydrochloride
Chemical Name: Opiranserin hydrochloride
CAS Number: 1440796-75-7
Molecular Formula: C₂₁H₃₅ClN₂O₅
Molecular Weight: 430.97
Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
Create Date: 2022-07-11 11:43:23
Modify Date: 2025-08-25 10:33:40
Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].

Name	Opiranserin hydrochloride

Description	Opiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A), with IC50s of 0.86 and 1.3 μM, respectively. Opiranserin hydrochloride shows antagonistic activity on rP2X3 (IC50=0.87 μM). Opiranserin hydrochloride is development as an injectable agent for the treatment of postoperative pain[1][2][3].
Related Catalog	Signaling Pathways >> Membrane Transporter/Ion Channel >> GlyT Signaling Pathways >> Membrane Transporter/Ion Channel >> P2X Receptor Research Areas >> Neurological Disease Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor Signaling Pathways >> Neuronal Signaling >> GlyT
Target	GlyT2:0.86 μM (IC50) 5-HT2A Receptor:1.3 μM (IC50) rP2X3:0.87 μM (IC50)
References	[1]. Oh J, et al. Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study. J Clin Pharmacol. 2018 Jan;58(1):64-73. [2]. Nedeljkovic SS, et al. Randomised, double-blind, parallel group, placebo-controlled study to evaluate the analgesic efficacy and safety of VVZ-149 injections for postoperative pain following laparoscopic colorectal surgery. BMJ Open. 2017 Feb 17;7(2):e011035. [3]. Pang MH, et al. A series of case studies: practical methodology for identifying antinociceptive multi-target drugs. Drug Discov Today. 2012 May;17(9-10):425-34.

Molecular Formula	C₂₁H₃₅ClN₂O₅
Molecular Weight	430.97

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1440796-75-7	1406-14-0
6138-79-0	127228-87-9
1334385-87-3	929-73-7
186694-02-0	143851-98-3
56-99-5	1406-02-6
1444190-94-6	1447962-30-2
1248910-71-5	1447963-25-8
1250601-68-3	1447962-20-0
1249883-09-7	1447962-35-7
1248156-17-3	1447960-27-1